🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Elimination

According to the social media company, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at residence.

Within moments of entering one community, a seller shared contact information, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Inside these communities, posts display dark colored packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously seen individuals injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant medical dangers”.